Differentiation of cytomegalovirus-specific CD8+ T cells in healthy and immunosuppressed virus carriers

Blood

Volumn 98, Issue 3, 2001, Pages 754-761

  Gamadia, Laila E ^a,b,c,d   Rentenaar, Rob J ^a,b,c,d   Baars, Paul A ^a,b,c,d   Remmerswaal, Ester B M ^a,b,c,d   Surachno, Sugianto ^a,b,c,d   Weel, Jan F L ^a,b,c,d   Toebes, Mireille ^a,b,c,d   Schumacher, Ton N M ^a,b,c,d   Ten Berge, Ineke J M ^a,b,c,d   Van Lier, René A W ^a,b,c,d  

^a Department of Internal Medicine Clinical Immunology Laboratory ^*  (Netherlands)

^b CENTRAL LABORATORY   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD27 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR7; GAMMA INTERFERON; GRANZYME B; HLA ANTIGEN; PERFORIN; TETRAMER;

ADULT; ANTIGEN SPECIFICITY; ARTICLE; CELL DIFFERENTIATION; CELL SPECIFICITY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOMEGALOVIRUS; EFFECTOR CELL; HELPER CELL; HLA SYSTEM; HUMAN; IMMUNE DEFICIENCY; INTERFERON PRODUCTION; KIDNEY TRANSPLANTATION; NONHUMAN; PERIPHERAL LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VIRUS CARRIER; VIRUS REACTIVATION; VIRUS REPLICATION;

EID: 0035437185     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.3.754     Document Type: Article

References (43)

1. Polic B, Hengel H, Krmpotic A, et al. Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection. J Exp Med. 1998;188:1047-1054.
2. + T lymphocytes. J Exp Med. 1989:169:1199-1212.
3. - T cell-mediated antiviral protection. J Immunol. 1999;162:2867-2874.
4. Rentenaar RJ, Gamadia LE, van der Hoek N, et al. Development of virus-specific CD4(+) T cells during primary cytomegalovirus infection. J Clin Invest. 2000;105:541-548.
5. Zajac AJ, Blattman JN, Murali-Krishna K, et al. Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med. 1998;188:2205-2213.
6. Murali-Krishna K, Altman JD, Suresh M, et al. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity. 1998;8:177-187.
7. + T cells. J Exp Med. 1997;186:1407-1418.
8. Azuma M, Cayabyab M, Phillips JH, Lanier LL. Requirements for CD28-dependent T cell-mediated cytotoxicity. J Immunol. 1993;150:2091-2101.
9. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 1999;401:708-712.
10. pos memory T-lymphocytes. Nephrol Dial Transplant. 1999;14:1430-1434.
11. Altman JD, Moss PH, Goulder PR, et al. Phenotypic analysis of antigen-specific T lymphocytes. Science. 1996;274:94-96.
12. Haanen JB, Toebes M, Cordaro TA, Wolkers MC, Kruisbeek AM, Schumacher TN. Systemic T cell expansion during localized viral infection. Eur J Immunol. 1999;29;1168-1174.
13. + T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency. J Clin Invest. 1997;99:1739-1750.
14. Kern F, Surel IP, Faulhaber N, et al. Target structures of the CD8(+)-T-cell response to human cytomegalovirus the 72-kilodalton major immediate-early protein revisited. J Virol. 1999;73:8179-8184.
15. Wever PC, Boonstra JG, Laterveer JC, et al. Mechanisms of lymphocyte-mediated cytotoxicity in acute renal allograft rejection. Transplantation. 1998;66:259-264.
16. + T-cell subset in peripheral blood from healthy individuals contains activated and apoptosis-prone cells. Immunology. 1998;93:383-389.
17. Campbell JJ, Murphy KE, Kunkel EJ, et al. CCR7 expression and memory T cell diversity in humans. J Immunol. 2001;166:877-884.
18. + T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. Proc Natl Acad Sci U S A. 1996:93:12433-12438.
19. - human T cells. J Immunol. 2000;165:1910-1917.
20. + T cells is controlled by T-cell receptor engagement. Nature. 2000;403:325-328.
21. + cytotoxic T-lymphocytes in liver transplant patients. Transplantation. 2000:69:2251-2259.
22. + T-helper and a T-killer cell. Nature. 1998;393:474-478.
23. Schoenberger SP, Toes RE, van der Voort E, Offringa R, Melief CJ. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature. 1998;393:480-483.
24. Kalams SA, Buchbinder SP. Rosenberg ES, et al. Association between virus-specific cytotoxic Tlymphocyte and helper responses in human immunodeficiency virus type 1 infection. J Virol. 1999;73:6715-6720.
25. Kalams SA, Walker BD. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses. J Exp Med. 1998;188:2199-2204.
26. + T cell responses associated with control of viremia. Science. 1997;278:1447-1450.
27. - T cell subset contains specialized primed T cells. J Immunol. 1995;154:17-25.
28. De Rie MA, Cairo I, van Lief RAW, Bos JD. Expression of the T-cell activation antigens CD27 and CD28 in normal and psoriatic skin. Clin Exp Dermatol. 1996;21:104-111.
29. Hol BE, Hintzen RQ, van Lier RAW, Alberts C, Out TA, Jansen HM. Soluble and cellular markers of T cell activation in patients with pulmonary sarcoidosis. Am Rev Respir Dis. 1993;148:643-649.
30. Walker LS, Gulbranson-Judge A, Flynn S. et al. Compromised OX40 function in CD28-deficient mice is linked with failure to develop CXC chemokine receptor 5-positive CD4 cells and germinal centers. J Exp Med. 1999;190:1115-1122.
31. Sallusto F, Kremmer E, Palermo B, et al. Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells. Eur J Immunol. 1999:29:2037-2045.
32. Hamann D, Roos MT, van Lier RAW. Faces and phases of human CD8 T-cell development. Immunol Today. 1999;20:177-180.
33. Ploegh HL. Viral strategies of immune evasion. Science. 1998;280:248-253.
34. Kotenko SV, Saccani S, Izotova LS, Mirochnitchenko OV, Pestka S. Human cytomegalovirus harbors its own unique IL-10 homolog. Proc Natl Acad Sci U S A. 2000;97:1695-1700.
35. Benedict CA, Butrovich KD, Lurain NS, et al. A novel viral TNF receptor superfamily member in virulent strains of human cytomegalovirus. J Immunol. 1999;162:6967-6970.
36. Farrell HE, Vally H, Lynch DM, et al. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Nature. 1997;386:510-514.
37. + T cells comprise both naive and memory cells. J Immunol. 1999;162:7080-7087.
38. Appay V, Nixon DF, Donahoe SM, et al. HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med. 2000;192:63-76.
39. Noble S, Markham A. Cyclosporin. A review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (Neoral). Drugs. 1995;50:924-941.
40. Hasenkrug KJ, Brooks DM, Dittmer U. Critical role for CD4(+) T cells in controlling retrovirus replication and spread in persistently infected mice. J Virol. 1998;72:6559-6564.
41. Rufer N, Brummendorf TH, Kolvraa S, et al. Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood. J Exp Med. 1999;190:157-167.
42. - T cells in healthy aging people, including centenarians. Immunology. 1996;88:501-507.
43. high T cell population. Eur J Immunol. 1993;23:1057-1063.